Core Alternative Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.9K | Hold |
306
| – | – | 0.01% | 146 |
|
|
2025
Q1 | $34.3K | Buy |
306
+241
| +371% | +$27K | 0.01% | 146 |
|
|
2024
Q4 | $6K | Hold |
65
| – | – | ﹤0.01% | 223 |
|
|
2024
Q3 | $5.45K | Hold |
65
| – | – | ﹤0.01% | 226 |
|
|
2024
Q2 | $4.46K | Hold |
65
| – | – | ﹤0.01% | 231 |
|
|
2024
Q1 | $4.76K | Sell |
65
-564
| -90% | -$41.3K | ﹤0.01% | 223 |
|
|
2023
Q4 | $51K | Sell |
629
-867
| -58% | -$70.3K | 0.01% | 167 |
|
|
2023
Q3 | $112K | Sell |
1,496
-24
| -2% | -$1.8K | 0.02% | 137 |
|
|
2023
Q2 | $117K | Buy |
1,520
+243
| +19% | +$18.7K | 0.02% | 114 |
|
|
2023
Q1 | $106K | Sell |
1,277
-1,100
| -46% | -$91.3K | 0.01% | 111 |
|
|
2022
Q4 | $204K | Buy |
2,377
+73
| +3% | +$6.27K | 0.03% | 98 |
|
|
2022
Q3 | $142K | Buy |
2,304
+184
| +9% | +$11.3K | 0.02% | 100 |
|
|
2022
Q2 | $131K | Buy |
2,120
+170
| +9% | +$10.5K | 0.03% | 108 |
|
|
2022
Q1 | $116K | Buy |
1,950
+783
| +67% | +$46.6K | 0.03% | 109 |
|
|
2021
Q4 | $85K | Buy |
+1,167
| New | +$85K | 0.02% | 107 |
|